Eroğlu Filibeli B, Havare N, Erbak Yılmaz H, Yıldırım JG, Çatlı G, Dündar BN. Evaluation of Turner syndrome knowledge among physicians and parents. J Clin Res Pediatr Endocrinol. 2020;12:95–103.
Peek R, Schleedoorn M, Smeets D, van de Zande G, Groenman F, Braat D, et al. Ovarian follicles of young patients with Turner’s syndrome contain normal oocytes but monosomic, 45 X granulosa cells. Hum Reprod. 2019;34:1686–96.
Gravholt CH, Viuff MH, Brun S, Stochholm K, Andersen NH. Turner syndrome: mechanisms and management. Nat Rev Endocrinol. 2019;15:601–14.
Schleedoorn MJ, van der Velden AAEM, Braat DDM, Peek R, Fleischer K. To freeze or not to freeze? An update on fertility preservation in females with Turner syndrome. Pediatr Endocrinol Rev. 2019;16:369–82.
Hreinsson JG, Otala M, Fridström M, Borgström B, Rasmussen C, Lundqvist M, et al. Follicles are found in the ovaries of adolescent girls with Turner’s syndrome. J Clin Endocrinol Metab. 2002;87:3618–23.
Jacobs P, Dalton P, James R, et al. Turner syndrome: a cytogenetic and molecular study. Ann Hum Genet. 1997;61:471–548.
Silberbach M, Roos-Hesselink JW, Andersen NH, Braverman AC, Brown N, Collins RT, et al. Cardiovascular health in Turner syndrome: a scientific statement from the American Heart Association. Circ Genom Precis Med. 2018;11:e000048.
Karnis MF, Zimon AE, Lalwani SI, et al. Risk of death in pregnancy achieved through oocyte donation in patients with Turner syndrome: a national survey. Fertil Steril. 2003;80:498.
Grewal J, Valente AM, Egbe AC, et al. Cardiovascular outcomes of pregnancy in Turner syndrome. Heart. 2021;107:61–6.
Calanchini M, Aye CYL, Orchard E, Baker K, Child T, Fabbri A, et al. Fertility issues and pregnancy outcomes in Turner syndrome. Fertil Steril. 2020;114:144–54.
Gravholt CH, Andersen NH, Conway GS, Dekkers OM, Geffner ME, Klein KO, Lin AE, Mauras N, Quigley CA, Rubin K, Sandberg DE, Sas TCJ, Silberbach M, Söderström-Anttila V, Stochholm K, van Alfen-van derVelden JA, Woelfle J, Backeljauw PF, International Turner syndrome consensus group. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol. 2017;177(3):G1–70. https://doi.org/10.1530/EJE-17-0430.
Vergier J, Bottin P, Saias J, et al. Fertility preservation in Turner syndrome: karyotype does not predict ovarian response to stimulation. Clin Endocrinol (Oxf). 2019;91:646.
Mamsen LS, Charkiewicz K, Anderson RA, et al. Characterization of follicles in girls and young women with Turner syndrome who underwent ovarian tissue cryopreservation. Fertil Steril. 2019;111:1217.
Oktay K, Bedoschi G, Berkowitz K, Bronson R, Kashani B, McGovern P, et al. Fertility preservation in women with Turner syndrome: a comprehensive review and practical guidelines. J Pediatr Adolesc Gynecol. 2016;29:409–16.
De Munck N, Santos-Ribeiro S, Stoop D, Van de Velde H, Verheyen G. Open versus closed oocyte vitrification in an oocyte donation programme: a prospective randomized sibling oocyte study. Hum Reprod. 2016;31:377–84.
Gardner DK, Schoolcraft WB. In-vitro culture of human blastocysts. In: Jansen R, Mortimer D, editors. Towards reproductive certainty: fertility and genetics beyond 1999. Carnforth: Parthenon Press; 1999. p. 378–88.
De Vos A, Van Landuyt L, De Rycke M, Verdyck P, Verheyen G, Buysse A, et al. Multiple vitrification-warming and biopsy procedures on human embryos: clinical outcome and neonatal follow-up of children. Hum Reprod. 2020;35:2488–96.
Van Landuyt L, Polyzos NP, De Munck N, Blockeel C, Van de Velde H, Verheyen G. A prospective randomized controlled trial investigating the effect of artificial shrinkage (collapse) on the implantation potential of vitrified blastocysts. Hum Reprod. 2015;30:2509–18.
Roelens C, Santos-Ribeiro S, Becu L, Mackens S, Van Landuyt L, Racca A, et al. Frozen-warmed blastocyst transfer after 6 or 7 days of progesterone administration: impact on live birth rate in hormone replacement therapy cycles. Fertil Steril. 2020;114:125–32.
Kavoussi SK, Fisseha S, Smith YR, Smith GD, Christman GM, Gago LA. Oocyte cryopreservation in a woman with mosaic Turner syndrome: a case report. J Reprod Med. 2008;53:223–6.
Cobo A, García-Velasco J, Domingo J, Pellicer A, Remohí J. Elective and Onco-fertility preservation: factors related to IVF outcomes. Hum Reprod. 2018;1(33):2222–31.
Giles J, Meseguer M, Mercader A, Rubio C, Alegre L, Vidal C, Trabalon M, Bosch E. Preimplantation genetic testing for aneuploidy in patients with partial X monosomy using their own oocytes: is this a suitable indication? Fertil Steril. 2020;114:346–53.
Purushothaman R, Lazareva O, Oktay K, Ten S. Markers of ovarian reserve in young girls with Turner’s syndrome. Fertil Steril. 2010;94:1557–9.
Miguel-Neto J, Carvalho AB, Marques-de-Faria AP, Guerra-Júnior G, Maciel-Guerra AT. New approach to phenotypic variability and karyotype-phenotype correlation in Turner syndrome. J Pediatr Endocrinol Metab. 2016;29:475–9.
Nadesapillai S, van der Velden J, Smeets D, van de Zande G, Braat D, Fleischer K, et al. Why are some patients with 45, X Turner syndrome fertile? A young girl with classical 45, X Turner syndrome and a cryptic mosaicism in the ovary. Fertil Steril. 2021;115:1280–7.
Nadesapillai S, van der Velden J, Braat D, Peek R, Fleischer K. The challenge of defining predictive parameters for fertility preservation counseling in young females with Turner syndrome. Acta Obstet Gynecol Scand. 2021;100:1155–6.
Oktay K, Bedoschi G. Oocyte cryopreservation for fertility preservation in postpubertal female children at risk for premature ovarian failure due to accelerated follicle loss in Turner syndrome or cancer treatments. J Pediatr Adolesc Gynaecol. 2014;27:342–6.
Oktay K, Rodriguez-Wallberg KA, Sahin G. Fertility preservation by ovarian stimulation and oocyte cryopreservation in a 14-year-old adolescent with Turner syndrome mosaicism and impending premature ovarian failure. Fertil Steril. 2010;94(2):753.e715-753.e759.
Nawroth F, Schüring AN, von Wolff M. The indication for fertility preservation in women with Turner syndrome should not only be based on the ovarian reserve but also on the genotype and expected future health status. Acta Obstet Gynecol Scand. 2020;99:1579–83.
Bryman I, Sylven L, Berntorp K, et al. Pregnancy rate and outcome in Swedish women with Turner syndrome. Fertil Steril. 2011;95:2507–10.
Hadnott TN, Gould HN, Gharib AM, Bondy CA. Outcomes of spontaneous and assisted pregnancies in Turner syndrome: the U.S. National Institutes of Health experience. Fertil Steril. 2011;95:2251–6.
Lucaccioni L, Wong SC, Smyth A, et al. Turner syndrome–issues to consider for transition to adulthood. Br Med Bull. 2015;113:45–58.